Hi Bav, I am more than happy with the information available both...

Hi Bav, I am more than happy with the information available both on the website, (and let's not forget the Investor hub), and what's posted here on hc.
None of my current holdings that provide as much, although that is only 5 other companies at the moment.
I look forward to the JP Morgan Conference with the focus rightly being Acer-cel our Allogeneic T-cell treatment, due to this being the nearest to potential FDA approval in 3-6 years.
We still don't know whether we will be licensing our treatments out or going it alone, I still believe it would not be unrealistic to think that someone with very
deep pockets will come in an underwrites our programs.
Also we may see a change in the way Government helps to fund these companies, as the cost of cancer treatments continue to become out of reach of the majority of cancer sufferers woman see Government put funds in earlier for phase2 and 3 trials in exchange for cheaper production of the drugs.


DYOR opinion only